# Biomed-Lublin to double Distreptaza production with new line

Biomed-Lublin is investing in a new Distreptaza production line that will double output and start operations in Q3 2018.

- Type: Expansion
- Announced: 2018-02-13
- Where: Poland
- Starts operating: Q3 2018
- Status: announced
- Capacity: double production
- Products: Distreptaza

## Companies

- [Biomed-Lublin](https://endata.com/companies/30018.md)

## Sources

- [rp.pl](https://www.rp.pl/biznes/art2121791-bioton-dystrybutorem-leku-biomedu), 2018-02-13: "Linia zacznie działać w trzecim kwartale br"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.